Our strategy is to develop our portfolio of innovative products for two large market categories, sexual health and pain, and then partner at the optimum time to generate most value.
The objective is to develop products such that each on its own has the potential to generate significant annual revenues.
We are investing in our lead product MED3000 to generate most value for shareholders.